Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis.

Christian Basile,Stefania Paolillo,Paola Gargiulo,Federica Marzano,Gaetano Asile, Antonio Luca Maria Parlati, Alfonsina Chirico,Ermanno Nardi,Davide Buonocore, Angela Colella,Pasquale Perrone-Filardi

Journal of cardiovascular medicine (Hagerstown, Md.)（2023）

引用 2|浏览8

暂无评分

摘要

This meta-analysis suggests that sacubitril-valsartan may be an effective strategy to reduce HF decompensation events in patients with HFpEF.Systematic Review registration: CRD42022336077.

查看译文

关键词

heart failure patients with preserved ejection fractions,meta-analysis,sacubitril,valsartan

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要